Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Tumor Necrosis Factor, Type II | 3 | 2020 | 357 | 1.290 |
Why?
|
| Sezary Syndrome | 2 | 2020 | 76 | 0.760 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 1 | 2020 | 32 | 0.730 |
Why?
|
| Antibodies, Neoplasm | 1 | 2020 | 286 | 0.680 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2020 | 139 | 0.620 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2020 | 329 | 0.530 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2020 | 2988 | 0.370 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3703 | 0.320 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2016 | 1832 | 0.310 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 3336 | 0.270 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10481 | 0.190 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 9274 | 0.170 |
Why?
|
| Transcription Factor RelA | 1 | 2017 | 275 | 0.130 |
Why?
|
| ATP-Dependent Proteases | 1 | 2014 | 27 | 0.120 |
Why?
|
| Ovarian Neoplasms | 2 | 2023 | 4838 | 0.110 |
Why?
|
| Peptides, Cyclic | 1 | 2014 | 400 | 0.100 |
Why?
|
| Mutation | 1 | 2016 | 29786 | 0.100 |
Why?
|
| Genome, Bacterial | 1 | 2016 | 760 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 6386 | 0.100 |
Why?
|
| Protease Inhibitors | 1 | 2014 | 791 | 0.090 |
Why?
|
| Mice | 5 | 2020 | 81183 | 0.090 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 3176 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4560 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3586 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 10943 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 2016 | 7181 | 0.070 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2703 | 0.070 |
Why?
|
| Aqueous Humor | 1 | 2006 | 161 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2017 | 5974 | 0.070 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2006 | 220 | 0.070 |
Why?
|
| Connexin 43 | 1 | 2006 | 207 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 4420 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 4803 | 0.060 |
Why?
|
| Animals | 5 | 2020 | 168757 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2020 | 4445 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 16689 | 0.060 |
Why?
|
| Tuberculosis | 1 | 2016 | 1912 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2017 | 19229 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 10180 | 0.050 |
Why?
|
| Platinum | 1 | 2023 | 233 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9438 | 0.040 |
Why?
|
| Models, Biological | 1 | 2016 | 9583 | 0.040 |
Why?
|
| Phenotype | 1 | 2016 | 16365 | 0.040 |
Why?
|
| Female | 4 | 2023 | 380194 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2020 | 1095 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 2242 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2020 | 1723 | 0.040 |
Why?
|
| Immunoassay | 1 | 2020 | 752 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2020 | 13815 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2020 | 1730 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2017 | 23403 | 0.030 |
Why?
|
| Humans | 5 | 2023 | 744343 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 1821 | 0.030 |
Why?
|
| Middle Aged | 2 | 2023 | 213383 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 3129 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 163280 | 0.020 |
Why?
|
| Gene Expression | 1 | 2020 | 7799 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 214055 | 0.020 |
Why?
|
| Ciliary Body | 1 | 2006 | 173 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2006 | 269 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2006 | 573 | 0.020 |
Why?
|
| Iris | 1 | 2006 | 239 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11031 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 9239 | 0.020 |
Why?
|
| Integrases | 1 | 2006 | 533 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2014 | 5456 | 0.010 |
Why?
|
| Male | 1 | 2020 | 350118 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11524 | 0.010 |
Why?
|
| Eye | 1 | 2006 | 729 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 2505 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21746 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 18111 | 0.010 |
Why?
|
| Intraocular Pressure | 1 | 2006 | 1270 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5686 | 0.010 |
Why?
|
| Cornea | 1 | 2006 | 1524 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 6171 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2023 | 63114 | 0.010 |
Why?
|
| Retina | 1 | 2006 | 2616 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 9734 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 4462 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 14557 | 0.010 |
Why?
|
Concepts
(81)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_